ASAH1
ASAH1[edit | edit source]
ASAH1 (N-acylsphingosine amidohydrolase 1) is an enzyme that plays a crucial role in the metabolism of sphingolipids, a class of lipids that are important components of cell membranes and involved in signaling pathways. ASAH1 is also known as acid ceramidase, as it catalyzes the hydrolysis of ceramide into sphingosine and a free fatty acid in the lysosome.
Function[edit | edit source]
ASAH1 is responsible for the breakdown of ceramide, a bioactive lipid that can influence cell growth, differentiation, and apoptosis. By converting ceramide into sphingosine, ASAH1 regulates the balance between ceramide and sphingosine, which is critical for maintaining cellular homeostasis. Sphingosine can be further phosphorylated to form sphingosine-1-phosphate (S1P), a potent signaling molecule involved in cell survival and proliferation.
Clinical Significance[edit | edit source]
Mutations in the ASAH1 gene can lead to a rare lysosomal storage disorder known as Farber disease. This condition is characterized by the accumulation of ceramide in various tissues, leading to symptoms such as joint deformities, subcutaneous nodules, and progressive neurological decline. The severity of Farber disease can vary, with some forms being rapidly progressive and others having a more chronic course.
ASAH1 has also been implicated in cancer biology. Altered ceramide metabolism, including changes in ASAH1 activity, has been observed in various types of cancer. Ceramide is known to induce apoptosis, and cancer cells often develop mechanisms to reduce ceramide levels, thereby promoting survival and resistance to chemotherapy.
Research and Therapeutic Potential[edit | edit source]
Given its role in sphingolipid metabolism and disease, ASAH1 is a target of interest for therapeutic intervention. Inhibitors of ASAH1 are being explored as potential treatments for cancer, aiming to increase ceramide levels and promote apoptosis in tumor cells. Conversely, enhancing ASAH1 activity could be beneficial in conditions where ceramide accumulation is detrimental, such as in Farber disease.
Also see[edit | edit source]
 | This enzyme-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
